ESR1 and breast cancer: Also, the sncRNAs identified as candidate prognostic markers for ER positive BC or as predictive markers may aid in distinguishing the ER positive cases with poorer outcome and provide knowledge of the mechanisms behind the insensitivity to RT and tamoxifen, and thus after further evaluation of their biological significance may offer targets for novel therapies.